By Mark Ellis —
Scientists in Israel are modifying an effective vaccine against “avian” Coronavirus Infectious Bronchitis Virus (IBV) to produce a human vaccine against Coronavirus (COVID-19), which seems to be on the verge of a global pandemic, creating havoc in the world economy.
‘The MIGAL Galilee Research Institute has achieved a scientific breakthrough that will lead to the rapid creation of a vaccine against Coronavirus in the coming weeks,” according to a report by The Jewish Voice (TJV).
MIGAL is an internationally recognized research institute that focuses on biotechnology, computer sciences, and plant science.
The effectiveness of the vaccine against IBV, a disease that afflicts poultry, has already been established in trials at Israel’s Veterinary Institute.
MIGAL made genetic changes to adapt the existing vaccine to COVID-19, and is in a process that will lead to preclinical testing and production of a vaccine.
“Research conducted at MIGAL has revealed that the poultry Coronavirus has high genetic similarity to the human COVID-19 and that it uses the same infection mechanism, a fact that increases the likelihood of achieving an effective human vaccine in a very short time,” according to the report by TJV.
The team at MIGAL is working at breakneck speed. “Our goal is to produce the vaccine during the next 8-10 weeks, and to achieve safety approval in 90 days,” David Zigdon, CEO of MIGAL, told TJV.
They are creating an oral vaccine, which will promote accessibility to the public.
“A few cases of Corona have been sighted in Israel, mostly Israelis returning from the east, and possibly some who have come in contact with tourists from South Korea who were already ill with the virus, but there has yet to be a widespread outbreak in the country.”
COVID-19 is affecting 53 countries worldwide.
The current death rate is 3.3 per 100 people, according to statistics reported by various countries, but some question the veracity of China and Iran’s figures.
